SIM
SGYP

Spark Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Spark Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-110,900
Closed -$337K – 800
2014
Q4 		$337K Buy
+110,900
New +$328K 0.06% 392

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spark Investment Management's SGYP Position: Q1 2015 in Review

Spark Investment Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2015, closing a stake of 110,900 shares — an estimated $337K sold.

Spark Investment Management first reported a position in SGYP in Q4 2014 and held it in 1 quarter. The position peaked at $337K in Q4 2014. 85 funds tracked by Wall St. Rank hold SGYP as of Q1 2015.

  • Spark Investment Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2015 after selling out during the quarter.
  • Spark Investment Management sold 110,900 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2015, an estimated $337K.
  • Spark Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2014 and held it in 1 quarter.
  • Spark Investment Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $337K in Q4 2014.
  • 85 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2015.

Based on Spark Investment Management's 13F filing for Q1 2015, filed 12 May 2015.